Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Franceschini

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Klinische Wochenschrift|June 3, 1985
Familial disorders of plasma apolipoproteinsC R Sirtori, G Franceschini
The New England Journal of Medicine|January 7, 1998
Probucol and multivitamins in the prevention of restenosis after coronary angioplastyC R Sirtori, G Franceschini
Pharmacology & Therapeutics|January 1, 1988
Effects of fibrates on serum lipids and atherosclerosisC R Sirtori, G Franceschini
Minerva Anestesiologica|January 1, 1973
[Monitoring of respiration]L Sarcinelli, G Franceschini, M Meletti
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|April 24, 2002
Control of chaotic spatiotemporal spiking by time-delay autosynchronizationG Franceschini, S Bose, E Schöll
Annali Italiani Di Chirurgia|August 31, 1999
[Axillary lymphadenectomy]A Picciocchi, D Terribile, G Franceschini
Pharmacology & Therapeutics|January 1, 1994
Drug control of reverse cholesterol transportG Franceschini, J P Werba, L Calabresi
Progress in Clinical and Biological Research|January 1, 1988
Apolipoprotein AI-Milano: altered lipid binding properties in a human apolipoprotein variantG Franceschini, L Calabresi, C R Sirtori
The American Journal of Cardiology|August 22, 1983
Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levelsR Paoletti, G Franceschini, C R Sirtori
Atherosclerosis|January 27, 1999
Recombinant apolipoproteins for the treatment of vascular diseasesC R Sirtori, L Calabresi, G Franceschini
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Klinische Wochenschrift|June 3, 1985
Familial disorders of plasma apolipoproteinsC R Sirtori, G Franceschini
The New England Journal of Medicine|January 7, 1998
Probucol and multivitamins in the prevention of restenosis after coronary angioplastyC R Sirtori, G Franceschini
Pharmacology & Therapeutics|January 1, 1988
Effects of fibrates on serum lipids and atherosclerosisC R Sirtori, G Franceschini
Minerva Anestesiologica|January 1, 1973
[Monitoring of respiration]L Sarcinelli, G Franceschini, M Meletti
Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics|April 24, 2002
Control of chaotic spatiotemporal spiking by time-delay autosynchronizationG Franceschini, S Bose, E Schöll
Annali Italiani Di Chirurgia|August 31, 1999
[Axillary lymphadenectomy]A Picciocchi, D Terribile, G Franceschini
Pharmacology & Therapeutics|January 1, 1994
Drug control of reverse cholesterol transportG Franceschini, J P Werba, L Calabresi
Progress in Clinical and Biological Research|January 1, 1988
Apolipoprotein AI-Milano: altered lipid binding properties in a human apolipoprotein variantG Franceschini, L Calabresi, C R Sirtori
The American Journal of Cardiology|August 22, 1983
Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levelsR Paoletti, G Franceschini, C R Sirtori
Atherosclerosis|January 27, 1999
Recombinant apolipoproteins for the treatment of vascular diseasesC R Sirtori, L Calabresi, G Franceschini
Pageof 16